Corona Remedies P/B Ratio
Corona Remedies (CORONA) P/B ratio is 13.32 (High), book value per share ₹122.46 vs Healthcare average P/B of -0.93 — Very High - Significant premium, high growth expectations or speculative. Compare with Corona Remedies value estimation to assess whether the stock is under or overvalued.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
CORONA P/B Ratio — Valuation Insights & Book Value Analysis
Corona Remedies price-to-book ratio interpretation, valuation status and historical context — current P/B 13.32 (High). View CORONA 52-week performance for the annual high/low range and current price position.
- Stock appears overvalued with PB of 13.32, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Trading at premium to sector average PB of -0.93
Corona Remedies P/B Ratio Historical Trend
CORONA annual price-to-book ratio — 2 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. For live price, earnings yield and the full fundamental profile, see Corona Remedies share price today.
CORONA Historical P/B Ratio — Book Value Per Share & Year-End Price
Corona Remedies annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 14.51 | ₹122.46 | ₹1777.30 | ₹747 | High |
| 2025 | 13.94 | ₹99.34 | ₹1384.90 | ₹606 | High |
CORONA vs Healthcare Peers — P/B Ratio Comparison
Corona Remedies P/B 13.32 vs Healthcare average -0.93, median 0.61 — range -31.21–1.04.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -31.21 | ₹25 | Low |
| Sun Pharma Advanced Rese… | SPARC | -16.05 | ₹5,310 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.31 | ₹75 | Low |
| Parmax Pharma | PARMAX | -2.16 | ₹12 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.76 | ₹121 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |